139 related articles for article (PubMed ID: 35337911)
41. Fabrication, optimisation and
Rawal S; Patel B; Patel MM
J Microencapsul; 2020 Dec; 37(8):543-556. PubMed ID: 32924677
[TBL] [Abstract][Full Text] [Related]
42. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Li J; Li J
J Pharm Pharmacol; 2021 Mar; 73(2):185-192. PubMed ID: 33793808
[TBL] [Abstract][Full Text] [Related]
43. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin.
Bapat P; Ghadi R; Chaudhari D; Katiyar SS; Jain S
Int J Pharm; 2019 Apr; 560():219-227. PubMed ID: 30776407
[TBL] [Abstract][Full Text] [Related]
44. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
45. Studies on the interaction between water and (hydroxypropyl)methylcellulose.
Nokhodchi A; Ford JL; Rubinstein MH
J Pharm Sci; 1997 May; 86(5):608-15. PubMed ID: 9145387
[TBL] [Abstract][Full Text] [Related]
46. Delivery of curcumin in a carboxymethyl cellulose and hydroxypropyl methyl cellulose carrier: Physicochemical properties and biological activity.
Wang S; Xie Y; Su H; Luo Y; Wang M; Li T; Fu Y
Int J Biol Macromol; 2023 Jun; 239():124203. PubMed ID: 37001776
[TBL] [Abstract][Full Text] [Related]
47. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
Chen Y; Pan L; Jiang M; Li D; Jin L
Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
[TBL] [Abstract][Full Text] [Related]
48. Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice.
Puglia C; Frasca G; Musumeci T; Rizza L; Puglisi G; Bonina F; Chiechio S
Eur J Pharm Biopharm; 2012 Jun; 81(2):288-93. PubMed ID: 22504443
[TBL] [Abstract][Full Text] [Related]
49. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.
Wang N; Zhang Y; Liu H; Wang A; Ren T; Gou J; Zhang Y; Yin T; He H; Tang X
Mol Pharm; 2020 Dec; 17(12):4533-4547. PubMed ID: 33201717
[TBL] [Abstract][Full Text] [Related]
50. Shortening replacement by emulsion and foam template hydroxypropyl methylcellulose (HPMC)-based oleogels in puff pastry dough. Rheological and texture properties.
Wang Q; Espert M; Salvador A; Sanz T
Curr Res Food Sci; 2023; 7():100558. PubMed ID: 37592957
[TBL] [Abstract][Full Text] [Related]
51. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
Park JB; Lim J; Kang CY; Lee BJ
Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
[TBL] [Abstract][Full Text] [Related]
52. Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity.
Aditya NP; Shim M; Lee I; Lee Y; Im MH; Ko S
J Agric Food Chem; 2013 Feb; 61(8):1878-83. PubMed ID: 23362941
[TBL] [Abstract][Full Text] [Related]
53. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
[TBL] [Abstract][Full Text] [Related]
54. A Hydroxypropyl Methylcellulose-Based Solid Dispersion of Curcumin with Enhanced Bioavailability and its Hepatoprotective Activity.
Shin MS; Yu JS; Lee J; Ji YS; Joung HJ; Han YM; Yoo HH; Kang KS
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31311168
[TBL] [Abstract][Full Text] [Related]
55. Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.
Bondì ML; Emma MR; Botto C; Augello G; Azzolina A; Di Gaudio F; Craparo EF; Cavallaro G; Bachvarov D; Cervello M
J Agric Food Chem; 2017 Feb; 65(7):1342-1352. PubMed ID: 28111949
[TBL] [Abstract][Full Text] [Related]
56. Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis.
Tavakoli N; Taymouri S; Saeidi A; Akbari V
Pharm Dev Technol; 2019 Sep; 24(7):891-901. PubMed ID: 31062987
[TBL] [Abstract][Full Text] [Related]
57. Green formulation of curcumin loaded lipid-based nanoparticles as a novel carrier for inhibition of post-angioplasty restenosis.
Akhlaghi S; Rabbani S; Alavi S; Alinaghi A; Radfar F; Dadashzadeh S; Haeri A
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110037. PubMed ID: 31546365
[TBL] [Abstract][Full Text] [Related]
58. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
[TBL] [Abstract][Full Text] [Related]
59. Antimicrobial Activity of Nanostructured Lipid Carriers Loaded
Fathi N; Lotfipour F; Dizaj SM; Hamishehkar H; Mohammadi M
Pharm Nanotechnol; 2020; 8(6):485-494. PubMed ID: 33407060
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.
Wang F; Chen J; Dai W; He Z; Zhai D; Chen W
Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
